Open AccessTreatment for liver metastases from breast cancer: Results and prognostic factors
Author(s) -
Xiaoping Li
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i24.3782
Subject(s) - medicine , breast cancer , chemotherapy , univariate analysis , oncology , metastasis , cancer , proportional hazards model , lymph node , gastroenterology , primary tumor , stage (stratigraphy) , liver cancer , multivariate analysis , paleontology , biology
Liver metastases from breast cancer (BCLM) are associated with poor prognosis. Cytotoxic chemotherapy can result in regression of tumor lesions and a decrease in symptoms. Available data, in the literature, also suggest a subgroup of patients may benefit from surgery, but few talked about transcatheter arterial chemoembolization (TACE). We report the results of TACE and systemic chemotherapy for patients with liver metastases from breast cancer and evaluate the prognostic factors.